Anterix Inc (ATEX) Stock Forecast
ATEX analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 3 analysts
- Price target
- $112.33 average of analyst targets
- Upside to target
- +39.6% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $-0.45
- 52-week range
- $17.99 – $108.20
ATEX analyst ratings
3 analystsNumber of analysts at each rating.
ATEX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ATEX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.28 | −$0.46 | $0.02 | $2.86 | −109.9% | 3 |
| Next quarter (Dec '26) | −$0.21 | −$0.50 | $0.28 | −$0.35 | +38.6% | 3 |
| Current fiscal year (FY2027) | −$1.11 | −$1.50 | −$0.73 | $4.83 | −123.1% | 2 |
| Next fiscal year (FY2028) | −$0.59 | −$2.07 | $2.06 | −$1.11 | +47.0% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ATEX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.0M | $2.0M | $2.0M | +27.1% | 3 |
| Next quarter (Dec '26) | $2.0M | $2.0M | $2.0M | +25.4% | 3 |
| Current fiscal year (FY2027) | $20.8M | $20.8M | $20.8M | +220.4% | 3 |
| Next fiscal year (FY2028) | $17.8M | $7.8M | $27.8M | −14.4% | 2 |
ATEX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ATEX revenue: reported and forecast
ATEX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.23 | $0.18 | $0.18 | −$0.04 | −$0.28 | +20.5% | 0 up · 0 down |
| Next quarter (Dec '26) | −$0.23 | $0.19 | $0.19 | −$0.04 | −$0.21 | −4.6% | 0 up · 0 down |
| Current fiscal year (FY2027) | −$1.33 | −$1.01 | −$1.56 | −$1.54 | −$1.11 | −16.0% | 0 up · 0 down |
| Next fiscal year (FY2028) | $0.00 | $4.51 | $4.51 | $1.26 | −$0.59 | — | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ATEX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ATEX beat in 9 of 12.
What analysts expect from ATEX
3 analysts cover Anterix; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $112.33, 39.6% above the latest close of $80.48. Analysts expect earnings of −$1.11 per share for FY2027, −123.1% from a year earlier. For FY2028 the average estimate is −$0.59 per share on revenue of $17.8 million. Anterix beat the EPS estimate in 9 of the last 12 quarters.
Related: ATEX income statement, ATEX key metrics, ATEX chart. See the ATEX stock overview for the latest quote and news.
ATEX forecast FAQ
What is Anterix's price target?
The average analyst price target for Anterix is $112.33, 39.6% above the latest close of $80.48.
Is Anterix a buy, hold or sell?
Of 3 analysts covering Anterix, 1 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Anterix's EPS forecast?
Analysts forecast −$1.11 per share for FY2027 (range −$1.50 to −$0.73); for FY2028 the estimate is −$0.59.
What is Anterix's revenue forecast?
The average revenue estimate for FY2027 is $20.8 million, growth of 220.4%; for FY2028 it is $17.8 million.
When does Anterix report earnings?
Anterix is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes; the EPS estimate is $-0.45.
Does Anterix usually beat earnings estimates?
Anterix reported EPS at or above the analyst estimate in 9 of the last 12 quarters.